Site içinde arama yapın

Ankit Chand bir ses eklendi Health
2025-05-13 09:39:43 -

ATTR Amyloidosis Treatment Market is driven by emerging gene therapies
The ATTR Amyloidosis Treatment Market involves pharmaceutical and biotech products designed to treat transthyretin amyloidosis, a rare disorder caused by misfolded transthyretin proteins that deposit as amyloid fibrils in multiple organs. Key therapies include TTR stabilizers, gene-silencing oligonucleotides, and monoclonal antibodies, each offering distinct advantages like improved patient...

0 Yorumlar 0 hisse senetleri 41 Views 0 önizleme

Please log in to like, share and comment!
Khushbu Coherent bir ses eklendi Health
2025-05-09 07:49:28 -

ATTR Amyloidosis Treatment Market is driven by Innovation
The ATTR Amyloidosis Treatment Market encompasses therapies focused on transthyretin stabilization and gene-silencing approaches to manage cardiomyopathy and polyneuropathy arising from amyloid fibril deposition. Market products include TTR stabilizers such as tafamidis and diflunisal, RNA interference (RNAi) drugs like patisiran, and antisense oligonucleotides exemplified by inotersen. These...

0 Yorumlar 0 hisse senetleri 145 Views 0 önizleme

Please log in to like, share and comment!